2021 House Bill 5262 / 2022 Public Act 42

Revise certain opioid-related drug prescription procedures

Introduced in the House

Aug. 17, 2021

Introduced by Rep. Abdullah Hammoud (D-15)

To require health insurers to provide new customers a nonopioid directive form to insureds upon enrollment. This is a form that indicates to prescribers and pharmacists that an individual must not be administered an opioid or offered a prescription for an opioid. See House Bill 5261.

Referred to the Committee on Health Policy

Nov. 4, 2021

Reported without amendment

With the recommendation that the substitute (H-2) be adopted and that the bill then pass.

Nov. 10, 2021

Substitute offered by Rep. Abdullah Hammoud (D-15)

To replace the previous version of the bill with one that revises details but does not change the substance as previously described.

The substitute passed by voice vote

Dec. 1, 2021

Passed in the House 91 to 9 (details)

Received in the Senate

Dec. 2, 2021

Referred to the Committee on Health Policy and Human Services

March 8, 2022

Reported without amendment

With the recommendation that the substitute (S-1) be adopted and that the bill then pass.

March 10, 2022

Passed in the Senate 38 to 0 (details)

To require health insurers to provide new customers a nonopioid directive form to insureds upon enrollment. This is a form that indicates to prescribers and pharmacists that an individual must not be administered an opioid or offered a prescription for an opioid. See House Bill 5261.

Received in the House

March 10, 2022

March 15, 2022

Passed in the House 93 to 10 (details)

To require health insurers to provide a nonopioid directive form to newly insured individuals upon enrollment. This is a form that indicates to prescribers and pharmacists that an individual must not be administered an opioid or offered a prescription for an opioid. See House Bill 5261.

Signed by Gov. Gretchen Whitmer

March 23, 2022